E-cadherin conventionally acts as an invasion suppressor in the majority of tumors and is generally downregulated; in contrast, N-cadherin, regarded as the promoter of oncogenes, is upregulated in metastatic cancer cells; these two cadherins maintain the balance of invasion [59]. The gene discussed is CDH1; the disease is metastatic malignant neoplasm.